伊宁怀孕59天不想要怎么办伊宁看妇科医院哪里有,伊宁治疗宫颈糜烂多少钱呢,伊宁不要孩子多少钱合理,伊宁上环后取环时间,伊宁看妇科病哪家比较专业,伊宁妇科检查哪家医院比较好,伊宁哪些阴道紧缩医院好

If all you ever wanted was only to eat the magically delicious marshmallows from a box of Lucky Charms, then today is your lucky day.General Mills announced that for a limited time only, they will sell marshmallow-only pouches of the sugary goodness. 258

Imagine Kevin James as Frank Underwood on "House of Cards."There is an online petition suggesting just that -- believe it or not -- and as of Tuesday, nearly 30,000 people have signed on to endorse the idea."Losing a great show is hard, no matter the circumstances," the petition reads. "However with hardship comes the opportunity for a great show to become one of the greatest television shows of all time. I think Kevin James can elevate 'House of Cards' to a globally adored franchise like 'Game of Thrones' and make the entire world focus on one of the most important Netflix original series there is."It's doubtful one Kevin will replace the other, but let's not pretend that television hasn't pulled big swaps before.Here are a few examples:Donna's death on "Kevin Can Wait"James is currently starring in the CBS sitcom "Kevin Can Wait," which recently killed off his character's wife, played by Erinn Hayes.Now, killing off a character is not out of the ordinary, but the show managed to make this particular plot twist especially awkward.Some "Kevin Can Wait" viewers complained that series treated the character's death too lightly, making a joke about her gym sending a postcard saying she was missed.James's character tells his daughter not to toss the card because "on the bottom, there's a coupon for a Kung-Fu lesson. I want to go there."James's former "King of Queens" costar, Leah Remini, was added to the cast, effectively making the show feel like "King of Queens 2.0."Original vs. new Becky on "Roseanne"Fans still like to argue over who was the better Becky on the hit 1990s sitcom "Roseanne."Actress Lecy Goranson played the eldest Conner child for the first five seasons, before leaving to go to college.Sarah Chalke was then recast in the role for Season 6, which some viewers didn't love.Goranson tried to work with the show -- reprising her role in Season 8 -- but ultimately Chalke became Becky full time.The whole thing turned into a running gag on "Rosanne," which would sometimes include jokes about the missing Goranson.The forthcoming "Roseanne" revival is set to have Goranson back as Becky and Chalke in another role.What happened to Judy on "Family Matters?"Judy Winslow went upstairs to her room one day and was never seen or heard from again.At least that's how fans of ABC's "Family Matters" felt like it all went down.The sitcom, which ran from 1989 to 1997, made the character Steve Urkle famous. But it was the disappearance of young Judy after four seasons that many viewers still talk about.Jaimee Foxworth, the actress who portrayed Judy, is now 37."The producers felt that they could do it [disappear her character] and no one would notice," Foxworth recently told The Root "They'd done it with previous shows they had," she said. "They figured no one would really care. My fans took notice of it."A tale of two Morgan Matthews on "Boy Meets World""Boy Meets World" thought they could pull one over on us when they swapped out actress Lily Nicksay, who played the scene-stealing sister Morgan, for actress Lindsay Ridgeway. Well, the second Morgan became forever known as "the other Morgan."Disney gave the 1990s show a bit of a reboot in 2014 with "Girl Meets World," which at the end of Season 3 brought both actresses back for the finale.It got ugly with Aunt Viv on "Fresh Prince of Bel Air"The original Aunt Viv, Janet Hubert, was beloved by fans for the first three seasons of the series which debuted in 1990.But the actress departed the NBC sitcom in 1993, and cast Daphne Maxwell Reid to play rapper Will Smith's aunt.In 2013, Hubert told "The Insider" that Smith fired her."He said 'We're just going to replace her and act like nothing happened," Hubert said at the time. "Well, honey, that is not what happened is it?"For his part, Smith reportedly said in a 1993 radio interview that he expected Hubert's anger."I can say straight up that Janet Hubert wanted the show to be 'The Aunt Viv of Bel Air Show,' because I know she is going to dog me in the press," he said. "She has basically gone from a quarter of a million dollars a year to nothing. She's mad now, but she's been mad all along."The-CNN-Wire 4169

I am committed to continuing to do the hard work to build trust in our communities as we work toward police accountability and racial justice.— Governor Kate Brown (@OregonGovBrown) September 28, 2020 208

If you weren't able to make it to the failed Fyre Festival, the U.S. Marshals are making it possible for you to own a piece of merchandise from the botched 2017 music festival.Consumers will be able to purchase t-shirts, baseball caps, and other merchandise online through the U.S. Marshals' auctioneer, Gaston & Sheehan. 333

How accurate are the coronavirus tests used in the U.S.?Months into the outbreak, no one really knows how well many of the screening tests work, and experts at top medical centers say it is time to do the studies to find out.When the new virus began spreading, the Food and Drug Administration used its emergency powers to OK scores of quickly devised tests, based mainly on a small number of lab studies showing they could successfully detect the virus.That’s very different from the large patient studies that can take weeks or months, which experts say are needed to provide a true sense of testing accuracy.The FDA’s speedy response came after it was initially criticized for delaying the launch of new tests during a crisis and after the Centers for Disease Control and Prevention stumbled in getting its own test out to states.But with the U.S. outbreak nearly certain to stretch on for months or even years, some experts want the FDA to demand better evidence of the tests’ accuracy so doctors know how many infections might be missed.There have been more than 2 million confirmed coronavirus cases in the U.S. and more than 115,000 deaths, according to data compiled by Johns Hopkins University. Cases in nearly half of U.S. states are rising.In recent weeks, preliminary findings have flagged potential problems with some COVID-19 tests, including one used daily at the White House. Faulty tests could leave many thousands of Americans with the incorrect assumption that they are virus-free, contributing to new flare-ups of the disease as communities reopen.“In the beginning, the FDA was under a lot of pressure to get these tests onto the marketplace,” said Dr. Steven Woloshin of Dartmouth College, who wrote about the issue in the New England Journal of Medicine last week. “But now that there are plenty of tests out there, it’s time for them to raise the bar.”The FDA said in a statement that it has already asked multiple test makers to do follow-up accuracy studies, although it didn’t say for how many of the more than 110 authorized screening tests. The agency also said it is tracking reports of problems. Accuracy has also been an issue with blood tests that look for signs of past infections.No screening test is 100% accurate. So details on accuracy are routinely provided for tests of all types, including seasonal flu, hepatitis, HIV and cancers. For example, rapid flu tests are known to miss 20% or more of all cases, a factor doctors weigh when treating patients who have symptoms but test negative.For now, most COVID-19 tests in the U.S. don’t give data on real-world performance, including how often the tests falsely clear patients of infection or falsely detect the virus. That information is lacking for all but a few of the roughly 80 commercial screening tests available, according to an Associated Press review.The government’s emergency authorization process “requires a lower level of evidence,” the agency said. Makers need only show that a test “may be effective” instead of the usual requirement to demonstrate “safety and effectiveness.” They would have to meet that higher threshold once the U.S. government declares the emergency over.Many of the commercial test makers submitted results from 60 samples, the minimum number required and mostly used lab-produced specimens of the virus. The FDA now recommends the use of nasal swabs or other real samples from people screened for coronavirus.Experts say larger patient studies patients are needed to assess a test’s true performance.Lab testing bears little resemblance to actual — sometimes imperfect — conditions at hospitals, clinics and testing sites noted Dr. Robert Kaplan of Stanford University.“You’re testing people in parking lots, the patients themselves are extremely anxious and often unable to follow instructions,” said Kaplan, a former associate director of the National Institutes of Health.Kaplan and others say those differences could explain why some tests are not performing as expected.Last month, the FDA warned doctors of a potential accuracy problem with Abbott Laboratories’ rapid ID Now test, which delivers results in roughly 15 minutes. The test has been lauded by President Donald Trump and used to screen the president, his staff and visitors to the White House.The FDA alert followed a preliminary report by New York University that found Abbott’s test missed between a third to one-half of infections caught by a rival test in patients screened for the virus.Abbott rejected the findings, saying the researchers did not follow the instructions for using its test. The company pointed to alternate patient studies, including its own, that have found the test successfully detects between 91% and 95% or more of virus cases when compared to other tests.But similar problems with ID NOW’s accuracy have been flagged in preliminary reports by researchers at Stanford University, Loyola University and the Cleveland Clinic.For now, the FDA is requiring Abbott to conduct follow-up studies in several different patient groups.The FDA’s emergency standards “are still high but there is a significant difference in the body of work that what would go into a submission under the normal process,” said Abbott vice president John Hackett. “Our normal process takes years to bring these out.”Requiring bigger studies of all coronavirus tests could provide valuable information, but it could also strain the FDA’s already stretched staff and resources, said Dr. Daniel Schultz, former director of the FDA’s medical device center.Dr. Colin West of the Mayo Clinic worries doctors and patients have put too much confidence in the current crop of tests, when an unknown number of patients with COVID-19 are likely receiving false negative results.Even a modest error rate can have grave consequences during an outbreak like COVID-19. West gives the example of a test that is 95% accurate at detecting the virus and is used on 1 million people. That would still result in 50,000 people being incorrectly told that they don’t have the virus.“The negative test does not mean that I’m off the hook,” West said. “We just need to maintain that level of vigilance until we have a better sense of how good these tests really can be.”___Follow Matthew Perrone on Twitter: @AP_FDAwriter.___Follow AP pandemic coverage at http://apnews.com/VirusOutbreak and https://apnews.com/UnderstandingtheOutbreak.___The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content. 6604